Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960
Published May 6, 2015 · Recall initiated: April 13, 2015
Summary
FDA records drug Class II recall D-0971-2015, published May 6, 2015 and initiated April 13, 2015. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Lot: Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp 8/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
What to do
Voluntary: Firm initiated · Letter
Get an email if FLUOXETINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- FLUOXETINE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide
- Lot
- Lot #: a) 6A208123, Exp 8/2015; b) 6A208121, Exp 8/2015.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFluoxetine Tablets, USP, 20 mg, 28-count Carton (4x7 Unit-dose), Manufactured by: TORRENT PHARMACEUTIALS LTD.,June 11, 2025
- FDAFluoxetine Tablets, USP, 20 mg, 30-count bottle, Rx only, Manufactured by: TORRENT PHARMACEUTIALS LTD.,June 11, 2025
- FDAGiant Eagle Buffalo Boneless Chicken Wings; PLU#: 27320; Sell By: (up to and including) 03/30/2015; Contains:May 6, 2015
- FDAThe PCA 3 infusion pump allows clinicians, or patients, to (self) Administer analgesia safely and effectivelyApril 29, 2015
- FDAFluoxetine Capsules USP, 20 mg, packaged in a) 100-count bottles (NDC 50111-648-01), b) 500-count bottles (NDCMay 7, 2014
- FDAFluoxetine Capsules USP, 10 mg, 100-count bottles, Rx only, Manufactured in Poland By: Pliva KrakowMay 7, 2014
Questions about this recall
Was Fluoxetine Capsules USP, 20 mg, packaged in a) 500-count bottles (NDC 50111-648-02), and (b) 1000- count bottles (NDC 50111-648-03), Rx only, Manufactured by Pliva Krakow Pharmaceutical Company S.A., Krakow, Poland; Manufactured for Teva Pharmaceuticals USA, Sellersville, PA 18960 recalled?
Yes. FDA published recall D-0971-2015 on May 6, 2015. Reported hazard: Chemical Contamination: Product recalled due to an elevated level of a residual solvent impurity in the API that exceeds the Threshold of Toxicological Concern (TTC) calculation for the impurity.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: FLUOXETINE.